OVARIAN CANCER: State of the Art
Panama City, 27-29 June 2019

[/vc_column]

 Timetable

Day 1
Gran Salón Ancón
07:30-07:50 Registry (HALL)
07:50-08:00 Welcome remarks
Mauricio Lema & Robert Coleman
08:00-08:40 PARP Inhibitors: The final solution?
Chair Mauricio Lema
Speaker Robert Coleman
08:30-08:40 Discussion
08:40-10:15 Baseline information on Ovarian cancer
Chair Robert Coleman
08:40-09:00 Genetics for Dummies
Ana Milena Gomez
09:00-09:20 BRCA testing: Who, What, Where, When, How and Why
Larissa Meyer
09:20-09:40 Ovarian cancer screening
Christina Fotopoulou
09:40-10:00 Discussion
10:00-10:20 Break
10:20-12:00 Pathobiology
Chair Angelica Nogueira
10:20-10:40 Ovarian Pathology, An Update
Anais Malpica
10:40-11:00 Pathogenesis and prevention
Shanon Westin
11:00-11:20 Clinical presentation
Larissa Meyer
11:20-11:40 Ovarian cancer in developing world
Audrey Tsunoda
11:40-12:00 Discussion
12:00-14:00 LUNCH
14:00-15:30 Primary interventions 
Chair Pedro Ramirez
14:00-14:20 Considerations for primary surgery
Shanon Westin
14:20-14:40 Role of imaging in primary/recurrent disease
Nicole Fleming
14:40-15:00 Laparoscopy in advanced disease
Ana Fagotti
15:00-15:20 Cytoreductive surgery techniques/outcomes
Reitan Ribeiro
15:20-15:30 Discussion
15:30-15:50 Break
15:50-16:50 Primary interventions 2
Chair Michael Frumovitz
15:50-16:10 Impact of LION trial
Christina Fotopoulou
16:10-16:30 NACT vs primary surgery
Nicole Fleming
16:30-16:40 MISSION Trial:Final analysis
Ana Fagotti
16:40-16:50 Discussion
16:50-17:10 Break
17:10-18:00 ERAS pathways in ovarian cancer
Chair TBA
Speaker Pedro Ramirez
17:40-18:00 Discussion
18:00 Adjourn
Day 2
Gran Salón Ancón
08:00-09:30 Adjuvant front-line treatment options
Chair Larissa Meyer
08:00-08:20 Adjuvant therapy standard of care
Carlos Vargas
08:20-08:40 IP Chemo: Raise and fall
Michael Frumovitz
08:40-09:00 Novel treat including: PARPi, Immunotherapy and angiogenesis
Shanon Westin
09:00-09:20 Adjuvant choices in developing world
Mauricio Lema
09:20-09:30 Discussion
09:30-09:50 Break
09:50-11:20 HIPEC real life indications
Chair Robert Coleman
09:50-10:10 How does HIPEC work?
Audrey Tsunoda
10:10-10:30 How to build a HIPEC service?
Michele De simone
10:30-10:50 HIPEC front line treatment/interval
Ana Fagotti
10:50-11:20 Should HIPEC be used on a regular basis?
Round table – All the speakers
11:20-12:10  I finished therapy…now what?
Chair Audrey Tsunoda
11:20 – 11:40 Surveillance after treatment
Angelica Nogueira
11:40 – 12:00 Patients reported outcomes in clinical practice
Larissa Meyer
12:00-12:10 Discussion
12:10-14:00 LUNCH
14:00-15:50 Recurrent disease
Chair Nicole Fleming
14:00-14:20 Options platinum sensitive disease
Carlos Vargas
14:20-14:40 Options in platinum-resistant disease
Mauricio Lema
14:40-15:00 GOG 213: Still we have to operate?
Robert Coleman
15:00-15:20 HIPEC recurrent disease
Michele De Simone
15:20-15:40 Biomarkers: Current status and development
Mauricio Lema
15:40-15:50 Discussion
15:50-16:10 Break
15:50-18:00 Interesting clinical situations
Chair Shanon Westin
16:10 – 16:30 Early stage disease – staging and treatment
Reitan Ribeiro
16:30-16:50 Fertility sparing options
René Pareja
16:50-17:10 Rare ovarian tumors (mucinous, small cell, carcinosarcoma, clear cell)
Michael Frumovitz
17:10-17:30 Sentinel node detection in ovarian cancer: Current evidence
Audrey Tsunoda
17:30-17:45 Low grade serous
Michael Frumovitz
17:45 Adjourn
Day 3
Gran Salón Ancón
08:00-10:00 Just for medical oncologists: Squeezing Coleman
Chair Mauricio Lema
6-8 cases for discussion on medical treatment alternatives
10:00-12:00 Just for surgeons
3-4 video presentations with interactive discussion
12:00 Closing remarks
René Pareja
Contact us

Send us an email and we'll get back to you, asap.

Not readable? Change text. captcha txt